| Literature DB >> 2124530 |
F H van den Hoogen1, A M Boerbooms, L B van de Putte.
Abstract
We reviewed studies concerning immunomodulating therapy in systemic sclerosis. These comprise mostly uncontrolled trials and case reports. Some of these studies hint at a possible beneficial effect of antimetabolites (azathioprine, 5-fluoro-uracil and methotrexate), cyclosporine and interferon-gamma. However, to give a clearcut answer on the efficacy of these drugs in systemic sclerosis, controlled studies are urgently needed.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2124530 DOI： 10.1007/bf02114391
Source DB: PubMed Journal: Clin Rheumatol ISSN： 0770-3198 Impact factor: 2.980